On Monday, Sana Biotechnology Inc (NASDAQ: SANA) opened lower -8.53% from the last session, before settling in for the closing price of $2.99. Price fluctuations for SANA have ranged from $1.52 to $12.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 17.68% at the time writing. With a float of $122.70 million, this company’s outstanding shares have now reached $223.11 million.
The firm has a total of 328 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Sana Biotechnology Inc (SANA) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Sana Biotechnology Inc is 45.04%, while institutional ownership is 52.51%. The most recent insider transaction that took place on Jan 16 ’25, was worth 289,500. Before that another transaction happened on Jan 08 ’25, when Company’s See Remark 1 sold 290,912 for $6.49, making the entire transaction worth $1,887,320. This insider now owns 4,541,511 shares in total.
Sana Biotechnology Inc (SANA) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 17.56% during the next five years compared to -83.13% drop over the previous five years of trading.
Sana Biotechnology Inc (NASDAQ: SANA) Trading Performance Indicators
Check out the current performance indicators for Sana Biotechnology Inc (SANA). In the past quarter, the stock posted a quick ratio of 4.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.41, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.87 in one year’s time.
Technical Analysis of Sana Biotechnology Inc (SANA)
Analysing the last 5-days average volume posted by the [Sana Biotechnology Inc, SANA], we can find that recorded value of 2.98 million was lower than the volume posted last year of 13.52 million. As of the previous 9 days, the stock’s Stochastic %D was 20.91%. Additionally, its Average True Range was 0.44.
During the past 100 days, Sana Biotechnology Inc’s (SANA) raw stochastic average was set at 21.02%, which indicates a significant increase from 4.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 111.65% in the past 14 days, which was lower than the 181.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.62, while its 200-day Moving Average is $4.81. Now, the first resistance to watch is $2.94. This is followed by the second major resistance level at $3.14. The third major resistance level sits at $3.27. If the price goes on to break the first support level at $2.61, it is likely to go to the next support level at $2.49. Should the price break the second support level, the third support level stands at $2.28.
Sana Biotechnology Inc (NASDAQ: SANA) Key Stats
There are currently 223,269K shares outstanding in the company with a market cap of 610.64 million. Presently, the company’s annual sales total 0 K according to its annual income of -283,260 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -59,920 K.
